These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2278761)

  • 1. Vaccination of children in Japan.
    Nishi M; Miyake H; Ito Y; Kagiichi S; Kimura M; Suzuki A; Takaoka A; Tago N; Nagase K
    Asia Pac J Public Health; 1990; 4(2-3):128-31. PubMed ID: 2278761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Morbidity and mortality of infectious diseases determined mass vaccination in children under 5 ans in Bamako District].
    Diawara A; Sangho H; Sango H; Sacko M; Sow S; Toure K; Doumbo O; Simaga SY;
    Mali Med; 2006; 21(4):8-11. PubMed ID: 19437838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Vaccination in childhood].
    Spiess H
    Dtsch Med Wochenschr; 1972 Jan; 97(4):125-31. PubMed ID: 4550326
    [No Abstract]   [Full Text] [Related]  

  • 4. Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001.
    Zhou F; Santoli J; Messonnier ML; Yusuf HR; Shefer A; Chu SY; Rodewald L; Harpaz R
    Arch Pediatr Adolesc Med; 2005 Dec; 159(12):1136-44. PubMed ID: 16330737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Norms o vaccination in the republic of Ecuador].
    Aroca Campodónico F; Baldeón Barros WG
    Rev Ecuat Hig Med Trop; 1969; 26(2):141-63. PubMed ID: 5400615
    [No Abstract]   [Full Text] [Related]  

  • 6. Diphtheria-tetanus-acellular pertussis and inactivated poliovirus vaccines given separately or combined for booster dosing at 4-6 years of age.
    Black S; Friedland LR; Ensor K; Weston WM; Howe B; Klein NP
    Pediatr Infect Dis J; 2008 Apr; 27(4):341-6. PubMed ID: 18316985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving child survival through immunisation.
    Lamabadusuriya SP
    Ceylon Med J; 1993 Dec; 38(4):170-1. PubMed ID: 8143330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term epidemiologic longitudinal study on the effect of vaccines on public inoculation.
    Matsuoka I; Matsuoka T; Matsuoka A; Shigemura T; Agematsu K; Koike K
    Turk J Pediatr; 2012; 54(4):376-81. PubMed ID: 23692718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Marin M; Broder KR; Temte JL; Snider DE; Seward JF;
    MMWR Recomm Rep; 2010 May; 59(RR-3):1-12. PubMed ID: 20448530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in varicella and mumps vaccination rates in children under 3 years of age in a tertiary children's hospital in Japan.
    Morikawa Y; Morino S; Ito K; Furuichi M; Miyokawa S; Shoji T; Horikoshi Y
    Pediatr Int; 2019 Sep; 61(9):882-888. PubMed ID: 31211889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-appropriate vaccination against measles and DPT-3 in India - closing the gaps.
    Awofeso N; Rammohan A; Iqbal K
    BMC Public Health; 2013 Apr; 13():358. PubMed ID: 23594400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress in timely vaccination coverage among children living in low-income households.
    Smith PJ; Jain N; Stevenson J; Männikkö N; Molinari NA
    Arch Pediatr Adolesc Med; 2009 May; 163(5):462-8. PubMed ID: 19414693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symposium on pertussis immunization, in honor of Dr. Pearl L. Kendrick in her eightieth year: current status of combined vaccines.
    Brown GC
    Health Lab Sci; 1971 Oct; 8(4):210-4. PubMed ID: 4940069
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunization coverage and natural infection rates of vaccine-preventable diseases among children by questionnaire survey in 2005 in Japan.
    Baba K; Okuno Y; Tanaka-Taya K; Okabe N
    Vaccine; 2011 Apr; 29(16):3089-92. PubMed ID: 20870055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse events associated with childhood vaccines other than pertussis and rubella. Summary of a report from the Institute of Medicine.
    Stratton KR; Howe CJ; Johnston RB
    JAMA; 1994 May; 271(20):1602-5. PubMed ID: 8182813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The Expanded Programme on Immunization in 1988].
    Levy-bruhl D
    Dev Sante; 1989 Dec; (84):18-22. PubMed ID: 12282918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity and safety of a combined measles, mumps, rubella and varicella live vaccine (ProQuad ®) administered concomitantly with a booster dose of a hexavalent vaccine in 12-23-month-old infants.
    Deichmann KA; Ferrera G; Tran C; Thomas S; Eymin C; Baudin M
    Vaccine; 2015 May; 33(20):2379-86. PubMed ID: 25765966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Worldwide control of disease through immunization. Progress and prospects.
    Hayden GF; Henderson RH
    Infect Dis Clin North Am; 1990 Jun; 4(2):245-58. PubMed ID: 2345289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence of antibodies in 4-8 year old Austrian children after vaccination with hexavalent DTaP-HBV-IPV/Hib and MMR vaccines.
    Paulke-Korinek M; Fischmeister G; Grac A; Rendi-Wagner P; Kundi M; Mohsenzadeh-Rabbani A; Moritz K; Fenninger B; Jarisch R; Jasinska J; Holzmann H; Wiedermann U; Kollaritsch H
    Vaccine; 2011 Jul; 29(32):5130-6. PubMed ID: 21624412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vaccine protection of Swedish children. Time for revision of replacing doses of diphtheria, tetanus, polio and pertussis].
    Olin P
    Lakartidningen; 2001 Aug; 98(35):3654-7. PubMed ID: 11577639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.